Early IL-17 production by intrahepatic T cells is important for adaptive immune responses in viral hepatitis

Journal of Immunology

Volumn 190, Issue 2, 2013, Pages 621-629

  Hou, Lifei ^a   Jie, Zuliang ^a   Desai, Mayura ^a   Liang, Yuejin ^a   Soong, Lynn ^a   Wang, Tian ^a   Sun, Jiaren ^a  

^a University of Texas Medical Branch School of Medicine   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INTERLEUKIN 17; INTERLEUKIN 23; INTERLEUKIN 7 RECEPTOR ALPHA; T LYMPHOCYTE RECEPTOR;

ADAPTIVE IMMUNITY; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; CYTOKINE PRODUCTION; CYTOKINE RELEASE; CYTOTOXIC T LYMPHOCYTE; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; GAMMA DELTA T LYMPHOCYTE; IMMUNE RESPONSE; IMMUNOCOMPETENT CELL; IN VITRO STUDY; INNATE IMMUNITY; LIVER PARENCHYMA; MOUSE; NONHUMAN; PRIORITY JOURNAL; T LYMPHOCYTE; TH1 CELL; VIRUS CELL INTERACTION; VIRUS HEPATITIS; VIRUS IMMUNITY; VIRUS NEUTRALIZATION;

ADAPTIVE IMMUNITY; ANIMALS; FEMALE; HEPATITIS, VIRAL, ANIMAL; HEPATOCYTES; INTERFERON TYPE I; INTERLEUKIN-17; INTERLEUKIN-23; INTERLEUKIN-7; LIVER; MICE; MICE, KNOCKOUT; RECEPTORS, ANTIGEN, T-CELL, GAMMA-DELTA; SIGNAL TRANSDUCTION; T-LYMPHOCYTE SUBSETS; T-LYMPHOCYTES;

EID: 84872177433     PISSN: 00221767     EISSN: 15506606     Source Type: Journal    
DOI: 10.4049/jimmunol.1201970     Document Type: Article

References (56)

1. Liu, M. A. 2010. Immunologic basis of vaccine vectors. Immunity 33: 504-515.
2. Worgall, S., G. Wolff, E. Falck-Pedersen, and R. G. Crystal. 1997. Innate immune mechanisms dominate elimination of adenoviral vectors following in vivo administration. Hum. Gene Ther. 8: 37-44.
3. Yang, Y., H. C. Ertl, and J. M. Wilson. 1994. MHC class I-restricted cytotoxic T lymphocytes to viral antigens destroy hepatocytes in mice infected with E1-deleted recombinant adenoviruses. Immunity 1: 433-442.
4. Yan, J., Z. Jie, L. Hou, J. L. Wanderley, L. Soong, S. Gupta, S. Qiu, T. Chan, and J. Sun. 2011. Parenchymal expression of CD40 exacerbates adenovirus-induced hepatitis in mice. Hepatology 53: 1455-1467.
5. Raper, S. E. 2005. Gene therapy: the good, the bad, and the ugly. Surgery 137: 487-492.
6. Zsengeller, Z. K., S. E. Wert, W. M. Hull, X. Hu, S. Yei, B. C. Trapnell, and J. A. Whitsett. 1995. Persistence of replication-deficient adenovirus-mediated gene transfer in lungs of immune-deficient (nu/nu) mice. Hum. Gene Ther. 6: 457-467.
7. Vilquin, J. T., B. Guérette, I. Kinoshita, B. Roy, M. Goulet, C. Gravel, R. Roy, and J. P. Tremblay. 1995. FK506 immunosuppression to control the immune reactions triggered by first-generation adenovirus-mediated gene transfer. Hum. Gene Ther. 6: 1391-1401.
8. Muruve, D. A., M. J. Barnes, I. E. Stillman, and T. A. Libermann. 1999. Adenoviral gene therapy leads to rapid induction of multiple chemokines and acute neutrophil-dependent hepatic injury in vivo. Hum. Gene Ther. 10: 965-976.
9. Liu, Z. X., S. Govindarajan, S. Okamoto, and G. Dennert. 2000. NK cells cause liver injury and facilitate the induction of T cell-mediated immunity to a viral liver infection. J. Immunol. 164: 6480-6486.
10. Ajuebor, M. N., Q. Chen, R. M. Strieter, P. A. Adegboyega, and T. Y. Aw. 2010. V(α)14iNKT cells promote liver pathology during adenovirus infection by inducing CCL5 production: implications for gene therapy. J. Virol. 84: 8520-8529.
11. Ajuebor, M. N., Y. Jin, G. L. Gremillion, R. M. Strieter, Q. Chen, and P. A. Adegboyega. 2008. GammadeltaT cells initiate acute inflammation and injury in adenovirus-infected liver via cytokine-chemokine cross talk. J. Virol. 82: 9564-9576.
12. Martinez, J., X. Huang, and Y. Yang. 2008. Direct action of type I IFN on NK cells is required for their activation in response to vaccinia viral infection in vivo. J. Immunol. 180: 1592-1597.
13. Dong, C. 2008. TH17 cells in development: an updated view of their molecular identity and genetic programming. Nat. Rev. Immunol. 8: 337-348.
14. Feng, T., H. Qin, L. Wang, E. N. Benveniste, C. O. Elson, and Y. Cong. 2011. Th17 cells induce colitis and promote Th1 cell responses through IL-17 induction of innate IL-12 and IL-23 production. J. Immunol. 186: 6313-6318.
15. Ma, Y., L. Aymeric, C. Locher, S. R. Mattarollo, N. F. Delahaye, P. Pereira, L. Boucontet, L. Apetoh, F. Ghiringhelli, N. Casares, et al. 2011. Contribution of IL-17-producing γ δ T cells to the efficacy of anticancer chemotherapy. J. Exp. Med. 208: 491-503.
16. Lin, Y., S. Ritchea, A. Logar, S. Slight, M. Messmer, J. Rangel-Moreno, L. Guglani, J. F. Alcorn, H. Strawbridge, S. M. Park, et al. 2009. Interleukin-17 is required for T helper 1 cell immunity and host resistance to the intracellular pathogen Francisella tularensis. Immunity 31: 799-810.
17. McGeachy, M. J., and D. J. Cua. 2008. Th17 cell differentiation: the long and winding road. Immunity 28: 445-453.
18. Miossec, P., T. Korn, and V. K. Kuchroo. 2009. Interleukin-17 and type 17 helper T cells. N. Engl. J. Med. 361: 888-898.
19. Cui, Y., H. Shao, C. Lan, H. Nian, R. L. O'Brien, W. K. Born, H. J. Kaplan, and D. Sun. 2009. Major role of γ δ T cells in the generation of IL-17+ uveitogenic T cells. J. Immunol. 183: 560-567.
20. Roark, C. L., J. D. French, M. A. Taylor, A. M. Bendele, W. K. Born, and R. L. O'Brien. 2007. Exacerbation of collagen-induced arthritis by oligoclonal, IL-17-producing γ δ T cells. J. Immunol. 179: 5576-5583.
21. Blink, S. E., and S. D. Miller. 2009. The contribution of gammadelta T cells to the pathogenesis of EAE and MS. Curr. Mol. Med. 9: 15-22.
22. Hamada, S., M. Umemura, T. Shiono, K. Tanaka, A. Yahagi, M. D. Begum, K. Oshiro, Y. Okamoto, H. Watanabe, K. Kawakami, et al. 2008. IL-17A produced by gammadelta T cells plays a critical role in innate immunity against listeria monocytogenes infection in the liver. J. Immunol. 181: 3456-3463.
23. Shibata, K., H. Yamada, H. Hara, K. Kishihara, and Y. Yoshikai. 2007. Resident Vdelta1+ gammadelta T cells control early infiltration of neutrophils after Escherichia coli infection via IL-17 production. J. Immunol. 178: 4466-4472.
24. Lockhart, E., A. M. Green, and J. L. Flynn. 2006. IL-17 production is dominated by gammadelta T cells rather than CD4 T cells during Mycobacterium tuberculosis infection. J. Immunol. 177: 4662-4669.
25. Cai, Y., X. Shen, C. Ding, C. Qi, K. Li, X. Li, V. R. Jala, H. G. Zhang, T. Wang, J. Zheng, and J. Yan. 2011. Pivotal role of dermal IL-17-producing γδ T cells in skin inflammation. Immunity 35: 596-610.
26. Shichita, T., Y. Sugiyama, H. Ooboshi, H. Sugimori, R. Nakagawa, I. Takada, T. Iwaki, Y. Okada, M. Iida, D. J. Cua, et al. 2009. Pivotal role of cerebral interleukin-17-producing gammadeltaT cells in the delayed phase of ischemic brain injury. Nat. Med. 15: 946-950.
27. Jensen, K. D., X. Su, S. Shin, L. Li, S. Youssef, S. Yamasaki, L. Steinman, T. Saito, R. M. Locksley, M. M. Davis, et al. 2008. Thymic selection determines gammadelta T cell effector fate: antigen-naive cells make interleukin-17 and antigen-experienced cells make interferon gamma. Immunity 29: 90-100.
28. Ribot, J. C., A. deBarros, D. J. Pang, J. F. Neves, V. Peperzak, S. J. Roberts, M. Girardi, J. Borst, A. C. Hayday, D. J. Pennington, and B. Silva-Santos. 2009. CD27 is a thymic determinant of the balance between interferon-γ- and interleukin 17-producing gammadelta T cell subsets. Nat. Immunol. 10: 427-436.
29. Do, J. S., P. J. Fink, L. Li, R. Spolski, J. Robinson, W. J. Leonard, J. J. Letterio, and B. Min. 2010. Cutting edge: spontaneous development of IL-17-producing γ δ T cells in the thymus occurs via a TGF-beta 1-dependent mechanism. J. Immunol. 184: 1675-1679.
30. Sutton, C. E., S. J. Lalor, C. M. Sweeney, C. F. Brereton, E. C. Lavelle, and K. H. Mills. 2009. Interleukin-1 and IL-23 induce innate IL-17 production from gammadelta T cells, amplifying Th17 responses and autoimmunity. Immunity 31: 331-341.
31. Bonneville, M., R. L. O'Brien, and W. K. Born. 2010. Gammadelta T cell effector functions: a blend of innate programming and acquired plasticity. Nat. Rev. Immunol. 10: 467-478.
32. Cua, D. J., and C. M. Tato. 2010. Innate IL-17-producing cells: the sentinels of the immune system. Nat. Rev. Immunol. 10: 479-489.
33. Shibata, K., H. Yamada, R. Nakamura, X. Sun, M. Itsumi, and Y. Yoshikai. 2008. Identification of CD25+ γ δ T cells as fetal thymus-derived naturally occurring IL-17 producers. J. Immunol. 181: 5940-5947.
34. Yue, F. Y., A. Merchant, C. M. Kovacs, M. Loutfy, D. Persad, and M. A. Ostrowski. 2008. Virus-specific interleukin-17-producing CD4+ T cells are detectable in early human immunodeficiency virus type 1 infection. J. Virol. 82: 6767-6771.
35. Zhang, J.-Y., Z. Zhang, F. Lin, Z.-S. Zou, R.-N. Xu, L. Jin, J.-L. Fu, F. Shi, M. Shi, H.-F. Wang, and F.-S. Wang. 2010. Interleukin-17-producing CD4(+) T cells increase with severity of liver damage in patients with chronic hepatitis B. Hepatology 51: 81-91.
36. Basha, H. I., V. Subramanian, A. Seetharam, D. S. Nath, S. Ramachandran, C. D. Anderson, S. Shenoy, W. C. Chapman, J. S. Crippin, and T. Mohanakumar. 2011. Characterization of HCV-specific CD4+Th17 immunity in recurrent hepatitis C-induced liver allograft fibrosis. Am. J. Transplant. 11: 775-785.
37. Nagata, T., L. McKinley, J. J. Peschon, J. F. Alcorn, S. J. Aujla, and J. K. Kolls. 2008. Requirement of IL-17RA in Con A induced hepatitis and negative regulation of IL-17 production in mouse T cells. J. Immunol. 181: 7473-7479.
38. Zhao, N., J. Hao, Y. Ni, W. Luo, R. Liang, G. Cao, Y. Zhao, P. Wang, L. Zhao, Z. Tian, et al. 2011. Vg4 γδ T cell-derived IL-17A negatively regulates NKT cell function in Con A-induced fulminant hepatitis. J. Immunol. 187: 5007-5014.
39. Sun, J., B. Tumurbaatar, J. Jia, H. Diao, F. Bodola, S. M. Lemon, W. Tang, D. G. Bowen, G. W. McCaughan, P. Bertolino, and T.-S. Chan. 2005. Parenchymal expression of CD86/B7.2 contributes to hepatitis C virus-related liver injury. J. Virol. 79: 10730-10739.
40. Sawa, Y., Y. Arima, H. Ogura, C. Kitabayashi, J. J. Jiang, T. Fukushima, D. Kamimura, T. Hirano, and M. Murakami. 2009. Hepatic interleukin-7 expression regulates T cell responses. Immunity 30: 447-457.
41. Liu, X., S. Leung, C. Wang, Z. Tan, J. Wang, T. B. Guo, L. Fang, Y. Zhao, B. Wan, X. Qin, et al. 2010. Crucial role of interleukin-7 in T helper type 17 survival and expansion in autoimmune disease. Nat. Med. 16: 191-197.
42. Sun, J. R., F. Bodola, X. G. Fan, H. Irshad, L. Soong, S. M. Lemon, and T. S. Chan. 2001. Hepatitis C virus core and envelope proteins do not suppress the host's ability to clear a hepatic viral infection. J. Virol. 75: 11992-11998.
43. Desai, M. M., B. Gong, T. Chan, R. A. Davey, L. Soong, A. A. Kolokoltsov, and J. Sun. 2011. Differential, type I interferon-mediated autophagic trafficking of hepatitis C virus proteins in mouse liver. Gastroenterology 141: 674-685.
44. Crispe, I. N. 2001. Isolation of Mouse Intrahepatic Lymphocytes. John Wiley & Sons, Hoboken NJ.
45. Hou, L. F., S. J. He, X. Li, Y. Yang, P. L. He, Y. Zhou, F. H. Zhu, Y. F. Yang, Y. Li, W. Tang, and J. P. Zuo. 2011. Oral administration of artemisinin analog SM934 ameliorates lupus syndromes in MRL/lpr mice by inhibiting Th1 and Th17 cell responses. Arthritis Rheum. 63: 2445-2455.
46. Roark, C. L., P. L. Simonian, A. P. Fontenot, W. K. Born, and R. L. O'Brien. 2008. gammadelta T cells: an important source of IL-17. Curr. Opin. Immunol. 20: 353-357.
47. Cheng, L., Y. Cui, H. Shao, G. Han, L. Zhu, Y. Huang, R. L. O'Brien, W. K. Born, H. J. Kaplan, and D. Sun. 2008. Mouse gammadelta T cells are capable of expressing MHC class II molecules, and of functioning as antigen-presenting cells. J. Neuroimmunol. 203: 3-11.
48. Lee, L. F., R. Axtell, G. H. Tu, K. Logronio, J. Dilley, J. Yu, M. Rickert, B. Han, W. Evering, M. G. Walker, et al. 2011. IL-7 promotes T(H)1 development and serum IL-7 predicts clinical response to interferon-β in multiple sclerosis. Sci. Transl. Med. 3: 93ra68.
49. Jiang, Q., W. Q. Li, F. B. Aiello, R. Mazzucchelli, B. Asefa, A. R. Khaled, and S. K. Durum. 2005. Cell biology of IL-7, a key lymphotrophin. Cytokine Growth Factor Rev. 16: 513-533.
50. Mazzucchelli, R., and S. K. Durum. 2007. Interleukin-7 receptor expression: intelligent design. Nat. Rev. Immunol. 7: 144-154.
51. Korn, T., and F. Petermann. 2012. Development and function of interleukin 17-producing γδ T cells. Ann. N. Y. Acad. Sci. 1247: 34-45.
52. Kasten, K. R., P. S. Prakash, J. Unsinger, H. S. Goetzman, L. G. England, C. M. Cave, A. P. Seitz, C. N. Mazuski, T. T. Zhou, M. Morre, et al. 2010. Interleukin-7 (IL-7) treatment accelerates neutrophil recruitment through γ δ T-cell IL-17 production in a murine model of sepsis. Infect. Immun. 78: 4714-4722.
53. Bowen, D. G., M. Zen, L. Holz, T. Davis, G. W. McCaughan, and P. Bertolino. 2004. The site of primary T cell activation is a determinant of the balance between intrahepatic tolerance and immunity. J. Clin. Invest. 114: 701-712.
54. Pellegrini, M., T. Calzascia, J. G. Toe, S. P. Preston, A. E. Lin, A. R. Elford, A. Shahinian, P. A. Lang, K. S. Lang, M. Morre, et al. 2011. IL-7 engages multiple mechanisms to overcome chronic viral infection and limit organ pathology. Cell 144: 601-613.
55. Huarte, E., E. Larrea, R. Hernández-Alcoceba, C. Alfaro, O. Murillo, A. Arina, I. Tirapu, A. Azpilicueta, S. Hervás-Stubbs, S. Bortolanza, et al. 2006. Recombinant adenoviral vectors turn on the type I interferon system without inhibition of transgene expression and viral replication. Mol. Ther. 14: 129-138.
56. Guo, B., E. Y. Chang, and G. Cheng. 2008. The type I IFN induction pathway constrains Th17-mediated autoimmune inflammation in mice. J. Clin. Invest. 118: 1680-1690.